Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Coeur Commences Drilling at Silver North's Tim Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Welcome to May SBMer's
View:
Post by Pareto8020 on May 02, 2021 7:15pm

Welcome to May SBMer's

Here is what is on Howards to do list for the month of May:

• Finalize due diligence and agree on terms with new organization
• Complete an additional licensing agreement for the SGLT2 inhibitor in new markets
• Secure non-dilutive funding through anticipated collaborations
• Finalize Tinyi agreement
• Complete Phase I clinical trial in China for the SGLT2 Inhibitor and advance to Phase II
• Complete safety studies and enter clinical trial for anti-wrinkle compound
• Develop new anti-viral compounds and advance them into preclinical studies

I don't think he'll have to time to work at the hospital much this month.  Just get the animal diabetes contract signed with the 2 nationals and I'll be happy.
Comment by zerbo on May 02, 2021 7:49pm
If there is a Buyout coming, he won't have to worry about that list anymore.
Comment by Crazydan on May 02, 2021 10:10pm
What make you believe there might be a buyout!!!! Son stupid to even bring it out!!
Comment by zerbo on May 03, 2021 10:39am
Hi Crazy, you to have a wonderful day!
Comment by pointer on May 03, 2021 10:47am
This post has been removed in accordance with Community Policy
Sirona Biochem Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities